Cortés, Javier <br/><br/>
The next era of treatment for hormone receptor-positive, HER2-negative advanced breast cancer: Triplet combination-based endocrine therapies.  [electronic resource] 

 -  Cancer treatment reviews  Dec 2017 
 - 53-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1532-1967 
<br/><br/><label>Standard No.: </label>10.1016/j.ctrv.2017.09.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Breast Neoplasms--drug therapy<br/>Cyclin-Dependent Kinase 4--antagonists & inhibitors<br/>Cyclin-Dependent Kinase 6--antagonists & inhibitors<br/>Female<br/>Humans<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Protein Kinase Inhibitors--therapeutic use<br/>Receptor, ErbB-2--metabolism<br/>Receptors, Estrogen--metabolism<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors